Lymphocyte to Procalcitonin Ratio: A New Predictor of Prognosis and Mortality in Covid
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 535
- 试验地点
- 1
- 主要终点
- outcome
研究概览
简要总结
The lymphocyte/CRP ratio has been studied many times in covid-19 patients and has been proven to be an indicator of mortality as well as poor prognosis. In this study, the role of the lymphocyte/procalcitonin ratio in predicting the hospitalization status of patients, detection of findings on CT, need for mechanical ventilation, mortality and survival is aimed to be determined. The lymphocyte/procalcitonin ratio was found to be the strongest predictor of mortality and poor prognosis, especially in patients over 65 years of age.
详细描述
The lymphocyte/CRP ratio has been studied many times in covid-19 patients and has been proven to be an indicator of mortality as well as poor prognosis. In this study, the role of the lymphocyte/procalcitonin ratio in predicting the hospitalization status of patients, detection of findings on CT, need for mechanical ventilation, mortality and survival is aimed to be determined. The lymphocyte/procalcitonin ratio was found to be the strongest predictor of mortality and poor prognosis, especially in patients over 65 years of age. The auc value, PPV and specificity of the lymphocyte/procalcitonin ratio were higher than the lymphocyte/CRP ratio.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 23 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Covid19 PCR test positive
排除标准
- •Pregnancy Under 18 years old
结局指标
主要结局
outcome
时间窗: 30 days
The relationship between lymphocyte/procalcitonin ratio and 30-day mortality was analyzed.
次要结局
未报告次要终点
研究者
Teslime Eryavuz Şengül
medical doctor
Suleyman Demirel University